NPI | Name | Type | Address |
---|---|---|---|
DR. Darla R. Joure |
Individual |
1640 Century Center Pkwy Memphis, TN |
|
Stephanie Michelle Dowdy |
Individual |
3440 Carriage Ln Humboldt, TN |
|
DR. PHARMD Amanda Sue Cass |
Individual |
1301 Medical Center Dr Nashville, TN |
|
PHARMD Ryan Miller |
Individual |
1301 Medical Center Dr Ste 3907 Nashville, TN |
|
DR. PHARMD. Matthew Perciavalle |
Individual |
1301 Medical Center Dr Oncology Pharmacy Nashville, TN |
|
PHARMD Bradley Yelvington |
Individual |
1301 Medical Center Dr Rm 3907 Nashville, TN |
|
Jonathan Aston |
Individual |
1301 Medical Center Dr Rm 2906 Nashville, TN |
|
PHARMD Kendall Shultes |
Individual |
324 Cool Springs Blvd Ste A Franklin, TN |
|
DR. PHARMD Katie Scarlett Gatwood |
Individual |
1301 Medical Center Dr. Room 2776, Tvc Nashville, TN |
|
Manuel Cortez |
Individual |
1211 Medical Center Dr Nashville, TN |
|
DR. PHARMD BCOP Kathryn Ann Culos |
Individual |
1301 Medical Center Dr # 2639 Nashville, TN |
|
DR. PHARMD Jared Crumb |
Individual |
2108 Charlotte Ave Nashville, TN |
|
PHARMD Sarah Cimino |
Individual |
1301 Medical Center Dr Nashville, TN |
|
PHARMD Shannon M Parkey |
Individual |
1005 Makena Cove Way Knoxville, TN |
|
DR. PHARM.D., BCPS, BCOP Nancy M Nix |
Individual |
2 Professional Park Dr Ste 15 Johnson City, TN |
|
PHARMD, BCPS, BCOP Ashley Sant |
Individual |
1 Professional Park Dr Ste 21 Johnson City, TN |
|
Wesley Clint Glass |
Individual |
719 Thompson Ln Ste 24130 Nashville, TN |
|
Mikala Hillis |
Individual |
1211 Medical Center Dr Nashville, TN |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |